Ridgeback Capital Investments

Ridgeback Capital Investments as of Dec. 31, 2013

Portfolio Holdings for Ridgeback Capital Investments

Ridgeback Capital Investments holds 5 positions in its portfolio as reported in the December 2013 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Sangamo Biosciences (SGMO) 50.9 $40M 2.9M 13.89
Celldex Therapeutics 31.4 $25M 1.0M 24.21
D Stemline Therapeutics 12.6 $9.9M 507k 19.60
Arrowhead Research 3.8 $3.0M 279k 10.85
Geron Corporation (GERN) 1.4 $1.1M 225k 4.74